• Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
investor

€0.0

round
investor investor

€0.0

round
investor investor

€0.0

round
*

€2.0m

Seed
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2018201920202021202220232024
Revenues0000000000000000000000000000
% growth-166 %(66 %)(6 %)207 %58 %(26 %)
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x

Source: Company filings or news article

Notes (0)
More about 2Eyes Vision
Made with AI
Edit

2Eyes Vision is a technology company specializing in the development and commercialization of ophthalmic technologies. A spin-off from the Spanish National Research Council (CSIC), the company focuses on prevalent eye conditions like presbyopia and cataracts. It was co-founded by Dr. Carlos Dorronsoro, who serves as CEO, and Prof. Dr. Susana Marcos. Dr. Dorronsoro has an extensive background in optical physics and vision science, with experience at CSIC, Leica, and as a co-founder of four spin-off companies. The company is headquartered in Madrid, Spain.

The core product is the SimVis Gekko, a wearable, binocular, see-through visual simulator. This device allows patients to experience their vision with different multifocal corrections before undergoing intraocular lens (IOL) implantation for cataract or refractive surgery. It is not virtual reality; it provides a real-world visual experience through a wide field of view by using fast programmable liquid lenses that simulate various IOL models. The technology aims to reduce patient uncertainty, improve satisfaction with surgical outcomes, and enhance the doctor-patient dialogue. The latest version, SimVis Gekko2, includes a pupil monitoring system for better alignment.

2Eyes Vision's business model is B2B, selling the SimVis Gekko device to ophthalmology clinics and surgeons. The company has an international presence in 18 countries across four continents and works with specialized resellers. It has received regulatory clearance in key markets and operates a scalable manufacturing facility with ISO9001 certification. The technology is supported by over 25 scientific publications and protected by 8 international patent families.

Keywords: visual simulator, ophthalmic technology, presbyopia, cataracts, intraocular lens, SimVis Gekko, medical devices, ophthalmology, see-through display, eye care

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo